TY - JOUR A1 - Soeriyadi, Angela H. A1 - Ongley, Sarah E. A1 - Kehr, Jan-Christoph A1 - Pickford, Russel A1 - Dittmann, Elke A1 - Neilan, Brett A. T1 - Tailoring enzyme stringency masks the multispecificity of a lyngbyatoxin (indolactam alkaloid) nonribosomal peptide synthetase JF - ChemBioChem N2 - Indolactam alkaloids are activators of protein kinase C (PKC) and are of pharmacological interest for the treatment of pathologies involving PKC dysregulation. The marine cyanobacterial nonribosomal peptide synthetase (NRPS) pathway for lyngbyatoxin biosynthesis, which we previously expressed in E. coli, was studied for its amenability towards the biosynthesis of indolactam variants. Modification of culture conditions for our E. coli heterologous expression host and analysis of pathway products suggested the native lyngbyatoxin pathway NRPS does possess a degree of relaxed specificity. Site-directed mutagenesis of two positions within the adenylation domain (A-domain) substrate-binding pocket was performed, resulting in an alteration of substrate preference between valine, isoleucine, and leucine. We observed relative congruence of in vitro substrate activation by the LtxA NRPS to in vivo product formation. While there was a preference for isoleucine over leucine, the substitution of alternative tailoring domains may unveil the true in vivo effects of the mutations introduced herein. KW - a domain KW - indolactams KW - MbtH KW - natural products KW - teleocidin Y1 - 2021 U6 - https://doi.org/10.1002/cbic.202100574 SN - 1439-4227 SN - 1439-7633 VL - 23 IS - 3 PB - Wiley-VCH CY - Weinheim ER - TY - JOUR A1 - Baunach, Martin A1 - Chowdhury, Somak A1 - Stallforth, Pierre A1 - Dittmann-Thünemann, Elke T1 - The landscape of recombination events that create nonribosomal peptide diversity JF - Molecular biology and evolution : MBE N2 - Nonribosomal peptides (NRP) are crucial molecular mediators in microbial ecology and provide indispensable drugs. Nevertheless, the evolution of the flexible biosynthetic machineries that correlates with the stunning structural diversity of NRPs is poorly understood. Here, we show that recombination is a key driver in the evolution of bacterial NRP synthetase (NRPS) genes across distant bacterial phyla, which has guided structural diversification in a plethora of NRP families by extensive mixing andmatching of biosynthesis genes. The systematic dissection of a large number of individual recombination events did not only unveil a striking plurality in the nature and origin of the exchange units but allowed the deduction of overarching principles that enable the efficient exchange of adenylation (A) domain substrates while keeping the functionality of the dynamic multienzyme complexes. In the majority of cases, recombination events have targeted variable portions of the A(core) domains, yet domain interfaces and the flexible A(sub) domain remained untapped. Our results strongly contradict the widespread assumption that adenylation and condensation (C) domains coevolve and significantly challenge the attributed role of C domains as stringent selectivity filter during NRP synthesis. Moreover, they teach valuable lessons on the choice of natural exchange units in the evolution of NRPS diversity, which may guide future engineering approaches. KW - evolution KW - recombination KW - structural diversity KW - natural products KW - nonribosomal peptide synthetases KW - microbial ecology Y1 - 2021 U6 - https://doi.org/10.1093/molbev/msab015 SN - 0737-4038 SN - 1537-1719 VL - 38 IS - 5 SP - 2116 EP - 2130 PB - Oxford Univ. Press CY - Oxford ER - TY - THES A1 - Krumbholz, Julia T1 - Identification of chemical mediators that regulate the specialized metabolism in Nostoc punctiforme T1 - Identifizierung chemischer Mediatoren, die den spezialisierten Metabolismus in Nostoc punctiforme regulieren N2 - Specialized metabolites, so-called natural products, are produced by a variety of different organisms, including bacteria and fungi. Due to their wide range of different biological activities, including pharmaceutical relevant properties, microbial natural products are an important source for drug development. They are encoded by biosynthetic gene clusters (BGCs), which are a group of locally clustered genes. By screening genomic data for genes encoding typical core biosynthetic enzymes, modern bioinformatical approaches are able to predict a wide range of BGCs. To date, only a small fraction of the predicted BGCs have their associated products identified. The phylum of the cyanobacteria has been shown to be a prolific, but largely untapped source for natural products. Especially multicellular cyanobacterial genera, like Nostoc, harbor a high amount of BGCs in their genomes. A main goal of this study was to develop new concepts for the discovery of natural products in cyanobacteria. Due to its diverse setup of orphan BGCs and its amenability to genetic manipulation, Nostoc punctiforme PCC 73102 (N. punctiforme) appeared to be a promising candidate to be established as a model organism for natural product discovery in cyanobacteria. By utilizing a combination of genome-mining, bioactivity-screening, variations of culture conditions, as well as metabolic engineering, not only two new polyketides were discovered, but also first-time insights into the regulation of the specialized metabolism in N. punctiforme were gained during this study. The cultivation of N. punctiforme to very high densities by utilizing increasing light intensities and CO2 levels, led to an enhanced metabolite production, causing rather complex metabolite extracts. By utilizing a library of CFP reporter mutant strains, each strain reporting for one of the predicted BGCs, it was shown that eight out of 15 BGCs were upregulated under high density (HD) cultivation conditions. Furthermore, it could be demonstrated that the supernatant of an HD culture can increase the expression of four of the influenced BGCs, even under conventional cultivation conditions. This led to the hypothesis that a chemical mediator encoded by one of the affected BGCs is accumulating in the HD supernatant and is able to increase the expression of other BGCs as part of a cell-density dependent regulatory circuit. To identify which of the BGCs could be a main trigger of the presumed regulatory circuit, it was tried to activate four BGCs (pks1, pks2, ripp3, ripp4) selectively by overexpression of putative pathway-specific regulatory genes that were found inside the gene clusters. Transcriptional analysis of the mutants revealed that only the mutant strain targeting the pks1 BGC, called AraC_PKS1, was able to upregulate the expression of its associated BGC. From an RNA sequencing study of the AraC_PKS1 mutant strain, it was discovered that beside pks1, the orphan BGCs ripp3 and ripp4 were also upregulated in the mutant strain. Furthermore, it was observed that secondary metabolite production in the AraC_PKS1 mutant strain is further enhanced under high-light and high-CO2 cultivation conditions. The increased production of the pks1 regulator NvlA also had an impact on other regulatory factors, including sigma factors and the RNA chaperone Hfq. Analysis of the AraC_PKS1 cell and supernatant extracts led to the discovery of two novel polyketides, nostoclide and nostovalerolactone, both encoded by the pks1 BGC. Addition of the polyketides to N. punctiforme WT demonstrated that the pks1-derived compounds are able to partly reproduce the effects on secondary metabolite production found in the AraC_PKS1 mutant strain. This indicates that both compounds are acting as extracellular signaling factors as part of a regulatory network. Since not all transcriptional effects that were found in the AraC_PKS1 mutant strain could be reproduced by the pks1 products, it can be assumed that the regulator NvlA has a global effect and is not exclusively specific to the pks1 pathway. This study was the first to use a putative pathway specific regulator for the specific activation of BGC expression in cyanobacteria. This strategy did not only lead to the detection of two novel polyketides, it also gave first-time insights into the regulatory mechanism of the specialized metabolism in N. punctiforme. This study illustrates that understanding regulatory pathways can aid in the discovery of novel natural products. The findings of this study can guide the design of new screening strategies for bioactive compounds in cyanobacteria and help to develop high-titer production platforms for cyanobacterial natural products. N2 - Sekundärmetabolite, auch Naturstoffe genannt, werden von einer Vielzahl an Organismen, darunter Bakterien und Pilzen, hergestellt. Aufgrund ihrer Vielzahl an verschiedenen Bioaktivitäten, einschließlich pharmakologisch relevanter Wirkungen, sind mikrobielle Naturstoffe eine wichtige Grundlage für die Arzneimittelentwicklung. Naturstoffe werden durch eine Ansammlung lokal gruppierter Gene, sogenannten Biosynthese-Genclustern (BGC), im Genom kodiert. Moderne bioinformatische Methoden durchsuchen Genom-Daten nach Genen, die typische biosynthetische Enzyme kodieren. Auf Grundlage dessen können verschiedenste BGCs vorhergesagt werden. Bislang konnte allerdings nur für einen kleinen Teil der vorhergesagten BGCs das dazugehörige Produkt identifiziert und charakterisiert werden. Cyanobakterien sind nachweislich eine reichhaltige, aber weitestgehend unerschlossene Quelle für Naturstoffe. Insbesondere mehrzellige Gattungen, wie Nostoc, tragen eine Vielzahl an BGCs in ihren Genomen. Ein Hauptziel dieser Studie war es, neue Konzepte für die Entdeckungen von Naturstoffen in Cyanobakterien zu entwickeln. Nostoc punctiforme PCC 73102 (N. punctiforme) erwies sich als besonders geeigneter Stamm für diese Aufgabe, da er eine Vielzahl weitestgehend ununtersuchter Gencluster besitzt und zugänglich für genetische Modifikationen ist. Eine Kombination aus Genome Mining, Bioaktivitäts-Screening, verschiedenen Kultivierungsbedingungen und Metabolic Engineering führte zur Entdeckung zweier neuer Polyketide und gewährte im Verlauf der Studie erstmals Einblicke in den spezialisierten Metabolismus von N. punctiforme. Die Kultivierung von N. punctiforme in sehr hohen Zelldichten, ermöglicht durch sehr hohe Lichtintensitäten und erhöhte CO2-Verfügbarkeit, führte zu einer verstärkten Metabolitproduktion und komplexen Metabolitextrakten. Unter Verwendung einer Bibliothek von CFP-Reportermutanten, bei der jede Mutante eines der vorhergesagten BGCs repräsentiert, konnte gezeigt werden, dass 8 von 15 BGCs unter Hochzelldichte-Kultivierungsbedingungen hochreguliert wurden. Zudem zeigte sich, dass der Überstand einer dichten Kultur, auch unter konventionellen Kultivierungsbedingungen, vier der regulierten BGCs beeinflussen kann. Dies lässt vermuten, dass sich unter Hochzelldichte-Kultivierungsbedingungen ein chemischer Mediator, welcher von einem der beeinflussten BGCs produziert wird, im Überstand anhäuft und die Expression anderer BGCs als Teil eines zelldichte-abhängigen Regelkreises kontrollieren kann. Um herauszufinden, welches der BGCs ein Hauptauslöser des vermuteten Regelkreises sein könnte, wurde versucht die Expression von vier BGCs (pks1, pks2, ripp3, ripp4) mittels Überexpression von potentiell biosynthese-spezifischen regulatorischen Genen zu aktivieren. Eine transkriptionelle Analyse der Mutanten ergab, dass nur der Stamm, welcher das pks1 BGC aktivieren sollte (AraC_PKS1), einen positiven Effekt auf die Expression des zu erwartenden BGCs hatte. Eine RNA-Sequenzierungsstudie ergab, dass in der AraC_PKS1 Mutante neben dem pks1 BGC auch die kryptischen BGCs ripp3 und ripp4 eine erhöhte Transkription aufwiesen. Zudem wurde beobachtet, dass sich die Sekundärmetabolitproduktion in der Mutante durch Kultivierung unter erhöhten Licht-Intensitäten und CO2-Leveln erweitern lässt. Unabhängig von den Kultivierungsbedingungen, hat die erhöhte Produktion des pks1 Regulators NvlA in der Mutante einen Einfluss auf andere regulatorische Faktoren, wie Sigma-Faktoren und das RNA-Chaperon Hfq. Die Analyse des Zell- und Überstandsextrakts der AraC_PKS1 Mutante führte zur Entdeckung zweier neuer Polyketide, Nostoclid und Nostovalerolacton, welche beide vom pks1 BGC codiert werden. Die Zugabe dieser Polyketide zum N. punctiforme Wildtyp zeigte, dass diese in der Lage sind einen Teil der Sekundärmetabolit-Effekte der AraC_PKS1 Mutante zu reproduzieren. Dies lässt darauf schließen, dass beide Polyketide als Signalstoffe innerhalb eines regulatorischen Netzwerks agieren. Da nicht alle transkriptionellen Effekte der AraC_PKS1 Mutante durch die Zugabe der pks1 Produkte reproduziert werden konnten, ist anzunehmen, dass der Regulator NvlA einen globalen Effekt hat und nicht ausschließlich die pks1 Biosynthese reguliert. Diese Studie war die erste, welche einen potentiell biosynthese-spezifischen Regulator für die gezielte Aktivierung von BGC-Expression in Cyanobakterien verwendet hat. Diese Strategie führte neben der Entdeckung zweier neuer Polyketide, zu ersten Einblicken in den regulatorischen Mechanismus, der den spezialisierten Metabolismus in N. punctiforme kontrolliert. Diese Studie veranschaulicht, dass das Verstehen regulatorischer Mechanismen für die Entdeckung neuer Naturstoffe hilfreich sein kann. Die Studien-Ergebnisse können die Entwicklung neuer Screening-Strategien für bioaktive Metabolite in Cyanobakterien anregen und können dabei helfen Hochtiter-Produktionsplattformen für cyanobakterielle Naturstoffe zu entwickeln. KW - cyanobacteria KW - natural products KW - specialized metabolites KW - gene cluster activation KW - Nostoc punctiforme KW - Cyanobakterien KW - Sekundärmetabolite KW - Naturstoffe KW - Gencluster-Aktivierung Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-540240 ER - TY - JOUR A1 - Reyna-González, Emmanuel A1 - Schmid, Bianca A1 - Petras, Daniel A1 - Süssmuth, Roderich D. A1 - Dittmann, Elke T1 - Leader Peptide-Free In Vitro Reconstitution of Microviridin Biosynthesis Enables Design of Synthetic Protease-Targeted Libraries JF - Angewandte Chemie : a journal of the Gesellschaft Deutscher Chemiker ; International edition N2 - Microviridins are a family of ribosomally synthesized and post-translationally modified peptides with a highly unusual architecture featuring non-canonical lactone as well as lactam rings. Individual variants specifically inhibit different types of serine proteases. Here we have established an efficient in vitro reconstitution approach based on two ATP-grasp ligases that were constitutively activated using covalently attached leader peptides and a GNAT-type N-acetyltransferase. The method facilitates the efficient in vitro one-pot transformation of microviridin core peptides to mature microviridins. The engineering potential of the chemo-enzymatic technology was demonstrated for two synthetic peptide libraries that were used to screen and optimize microviridin variants targeting the serine proteases trypsin and subtilisin. Successive analysis of intermediates revealed distinct structure-activity relationships for respective target proteases. KW - biosynthesis KW - cyanobacteria KW - microviridins KW - natural products KW - peptides Y1 - 2016 U6 - https://doi.org/10.1002/anie.201604345 SN - 1433-7851 SN - 1521-3773 VL - 55 SP - 9398 EP - 9401 PB - Wiley-VCH CY - Weinheim ER - TY - THES A1 - Reyna González, Emmanuel T1 - Engineering of the microviridin post-translational modification enzymes for the production of synthetic protease inhibitors T1 - Manipulation der posttranslationalen Modifikationsenzyme von Microviridin zur Herstellung synthetischer Proteaseinhibitoren N2 - Natural products and their derivatives have always been a source of drug leads. In particular, bacterial compounds have played an important role in drug development, for example in the field of antibiotics. A decrease in the discovery of novel leads from natural sources and the hope of finding new leads through the generation of large libraries of drug-like compounds by combinatorial chemistry aimed at specific molecular targets drove the pharmaceutical companies away from research on natural products. However, recent technological advances in genetics, bioinformatics and analytical chemistry have revived the interest in natural products. The ribosomally synthesized and post-translationally modified peptides (RiPPs) are a group of natural products generated by the action of post-translationally modifying enzymes on precursor peptides translated from mRNA by ribosomes. The great substrate promiscuity exhibited by many of the enzymes from RiPP biosynthetic pathways have led to the generation of hundreds of novel synthetic and semisynthetic variants, including variants carrying non-canonical amino acids (ncAAs). The microviridins are a family of RiPPs characterized by their atypical tricyclic structure composed of lactone and lactam rings, and their activity as serine protease inhibitors. The generalities of their biosynthetic pathway have already been described, however, the lack of information on details such as the protease responsible for cleaving off the leader peptide from the cyclic core peptide has impeded the fast and cheap production of novel microviridin variants. In the present work, knowledge on leader peptide activation of enzymes from other RiPP families has been extrapolated to the microviridin family, making it possible to bypass the need of a leader peptide. This feature allowed for the exploitation of the microviridin biosynthetic machinery for the production of novel variants through the establishment of an efficient one-pot in vitro platform. The relevance of this chemoenzymatic approach has been exemplified by the synthesis of novel potent serine protease inhibitors from both rationally-designed peptide libraries and bioinformatically predicted microviridins. Additionally, new structure-activity relationships (SARs) could be inferred by screening microviridin intermediates. The significance of this technique was further demonstrated by the simple incorporation of ncAAs into the microviridin scaffold. N2 - Naturstoffe und ihre Derivate waren schon immer eine Quelle von Leitstrukturen. Insbesondere haben bakterielle Verbindungen eine wichtige Rolle bei der Arzneimittelentwicklung gespielt, zum Beispiel im Bereich der Antibiotika. Die Abnahme von Entdeckungen neuer Leitstrukturen aus natürlichen Quellen und die Hoffnung, neue Leitstrukturen in großen Bibliotheken medikamentenähnlicher Verbindungen zu finden, welche auf spezifische molekulare Ziele gerichtet sind und mithilfe kombinatorischer Chemie erstellt wurden, trieben die Pharmaunternehmen weg von der Naturstoffforschung. Allerdings haben moderne technologische Fortschritte in der Genetik, der Bioinformatik und der analytischen Chemie das Interesse an Naturstoffen wiederbelebt. Die ribosomal synthetisierten und posttranslational modifizierten Peptide (RiPPs) sind eine Gruppe von Naturstoffen, die durch das Einwirken posttranslational modifizierender Enzymen auf Präkursorpeptide entstehen, welche ihrerseits aus mRNA durch Translation an den Ribosomen hervorgehen. Die durch viele der Enzyme aus RiPP Biosynthesewege gezeigte große Substrat- Promiskuität führte zur Erzeugung hunderter neuartiger synthetischer und halbsynthetischer Varianten, einschließlich Varianten mit nicht-kanonischen Aminosäuren. Die Microviridine sind eine Familie von RiPPs, die durch ihre atypische trizyklische Struktur aus Lacton- und Lactamringen und ihre Aktivität als Serin-Protease-Inhibitoren gekennzeichnet sind. Die Grundlagen ihres Biosyntheseweges sind bereits beschrieben worden, aber wesentliche Fragestellungen, zum Beispiel die für die Spaltung des Leader-Peptids vom zyklischen Core- Peptid verantwortliche Protease betreffend, sind weitgehend ungeklärt und erschweren die schnelle und kostengünstige Herstellung neuer Microviridinvarianten. In der vorliegenden Arbeit wurde das Wissen über die durch Leader-Peptid Aktivierung von Enzymen aus anderen RiPP-Familien auf die Microviridinfamilie extrapoliert, wodurch es möglich wurde, die Notwendigkeit eines Leader-Peptids zu umgehen. Diese Besonderheit erlaubt nunmehr, die Microviridin-Biosynthese-Enzyme für die Herstellung von neuartigen Varianten durch die Etablierung einer effizienten in vitro Synthese-Plattform auszunutzen. Die Relevanz dieses chemoenzymatischen Ansatzes wurde durch die Synthese von neuen potenten Serin-Protease- Inhibitoren aus sowohl rational gestalteten Peptidbibliotheken als auch bioinformatisch vorhergesagten Microviridinen veranschaulicht. Darüber hinaus wurden durch das Screenen von Microviridinzwischenprodukten neue Struktur-Funktionsbeziehungen abgeleitet. Die Bedeutung dieser Technik wurde durch den einfachen Einbau von nicht-kanonischen Aminosäuren in das Microviridin-Gerüst weiter demonstriert. KW - RiPP KW - microviridin KW - biosynthesis KW - natural products KW - peptide KW - protease inhibitor KW - Biosynthese KW - Naturstoffe KW - cyanobacteria KW - Cyanobakterien KW - Microviridin KW - Protease-Inhibitoren Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-406979 ER - TY - JOUR A1 - Kehr, Jan-Christoph A1 - Picchi, Douglas Gatte A1 - Dittmann-Thünemann, Elke T1 - Natural product biosyntheses in cyanobacteria a treasure trove of unique enzymes JF - Beilstein journal of organic chemistry N2 - Cyanobacteria are prolific producers of natural products. Investigations into the biochemistry responsible for the formation of these compounds have revealed fascinating mechanisms that are not, or only rarely, found in other microorganisms. In this article, we survey the biosynthetic pathways of cyanobacteria isolated from freshwater, marine and terrestrial habitats. We especially emphasize modular nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) pathways and highlight the unique enzyme mechanisms that were elucidated or can be anticipated for the individual products. We further include ribosomal natural products and UV-absorbing pigments from cyanobacteria. Mechanistic insights obtained from the biochemical studies of cyanobacterial pathways can inspire the development of concepts for the design of bioactive compounds by synthetic-biology approaches in the future. KW - cyanobacteria KW - natural products KW - NRPS KW - PKS KW - ribosomal peptides Y1 - 2011 U6 - https://doi.org/10.3762/bjoc.7.191 SN - 1860-5397 VL - 7 IS - 2 SP - 1622 EP - 1635 PB - Beilstein-Institut zur Förderung der Chemischen Wissenschaften CY - Frankfurt, Main ER - TY - JOUR A1 - Schmidt, Bernd A1 - Kunz, Oliver T1 - Bidirectional cross metathesis and ring-closing metathesis/ring opening of a C-2-symmetric building block: a strategy for the synthesis of decanolide natural products JF - Beilstein journal of organic chemistry N2 - Starting from the conveniently available ex-chiral pool building block (R,R)-hexa-1,5-diene-3,4-diol, the ten-membered ring lactones stagonolide E and curvulide A were synthesized using a bidirectional olefin-metathesis functionalization of the terminal double bonds. Key steps are (i) a site-selective cross metathesis, (ii) a highly diastereoselective extended tethered RCM to furnish a (Z,E)-configured dienyl carboxylic acid and (iii) a Ru-lipase-catalyzed dynamic kinetic resolution to establish the desired configuration at C9. Ring closure was accomplished by macrolactonization. Curvulide A was synthesized from stagonolide E through Sharpless epoxidation. KW - dienes KW - enzyme catalysis KW - lactones KW - metathesis KW - natural products KW - ruthenium Y1 - 2013 U6 - https://doi.org/10.3762/bjoc.9.289 SN - 1860-5397 VL - 9 SP - 2544 EP - 2555 PB - Beilstein-Institut zur Förderung der Chemischen Wissenschaften CY - Frankfurt, Main ER - TY - GEN A1 - Bringmann, Gerhard A1 - Mutanyatta-Comar, Joan A1 - Maksimenka, Katja A1 - Wanjohi, John M. A1 - Heydenreich, Matthias A1 - Brun, Reto A1 - Müller, Werner E. G. A1 - Peter, Martin A1 - Midiwo, Jacob O. A1 - Yenesew, Abiy T1 - Joziknipholones A and B : the First Dimeric Phenylanthraquinones, from the Roots of Bulbine frutescens N2 - From the roots of the African plant Bulbine frutescens (Asphodelaceae), two unprecedented novel dimeric phenylanthraquinones, named joziknipholones A and B, possessing axial and centrochirality, were isolated, together with six known compounds. Structural elucidation of the new metabolites was achieved by spectroscopic and chiroptical methods, by reductive cleavage of the central bond between the monomeric phenylanthraquinone and -anthrone portions with sodium dithionite, and by quantum chemical CD calculations. Based on the recently revised absolute axial configuration of the parent phenylanthraquinones, knipholone and knipholone anthrone, the new dimers were attributed to possess the P-configuration (i.e., with the acetyl portions below the anthraquinone plane) at both axes in the case of joziknipholone A, whereas in joziknipholone B, the knipholone part was found to be M-configured. Joziknipholones A and B are active against the chloroquine resistant strain K1 of the malaria pathogen, Plasmodium falciparum, and show moderate activity against murine leukemic lymphoma L5178y cells. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - paper 104 KW - antimalarial activity KW - chirality KW - joziknipholones KW - natural products KW - structure elucidation Y1 - 2008 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-42638 ER -